TY - JOUR
T1 - Video capsule endoscopy in inflammatory bowel disease
AU - Limpias Kamiya, Kenji J.L.
AU - Hosoe, Naoki
AU - Hayashi, Yukie
AU - Kawaguchi, Takaaki
AU - Takabayashi, Kaoru
AU - Ogata, Haruhiko
AU - Kanai, Takanori
N1 - Publisher Copyright:
© 2021 The Authors. DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.
PY - 2022/4
Y1 - 2022/4
N2 - Since its introduction into clinical practice in 2000, capsule endoscopy (CE) has become an important procedure for many pathologies of small bowel (SB) diseases, including inflammatory bowel disease (IBD). Currently, the most commonly used capsule procedures are small bowel capsule endoscopy (SBCE), colon CE (CCE), and the recently developed pan-enteric CE that evaluates the SB and colon in patients with Crohn's disease (CD). SBCE has a higher diagnostic performance compared to other radiological and conventional endoscopic modalities in patients with suspected CD. Additionally, CE plays an important role in monitoring the activity of CD in SB. It can also be used in evaluating response to anti-inflammatory treatment and detecting recurrence in postsurgical patients with CD who underwent bowel resection. Due to its increasing use, different scoring systems have been developed specifically for IBD. The main target with CCE is ulcerative colitis (UC). The second-generation colon capsule has shown high performance for the assessment of inflammation in patients with UC. CCE allows noninvasive evaluation of mucosal inflammation with a reduced volume of preparation for patients with UC.
AB - Since its introduction into clinical practice in 2000, capsule endoscopy (CE) has become an important procedure for many pathologies of small bowel (SB) diseases, including inflammatory bowel disease (IBD). Currently, the most commonly used capsule procedures are small bowel capsule endoscopy (SBCE), colon CE (CCE), and the recently developed pan-enteric CE that evaluates the SB and colon in patients with Crohn's disease (CD). SBCE has a higher diagnostic performance compared to other radiological and conventional endoscopic modalities in patients with suspected CD. Additionally, CE plays an important role in monitoring the activity of CD in SB. It can also be used in evaluating response to anti-inflammatory treatment and detecting recurrence in postsurgical patients with CD who underwent bowel resection. Due to its increasing use, different scoring systems have been developed specifically for IBD. The main target with CCE is ulcerative colitis (UC). The second-generation colon capsule has shown high performance for the assessment of inflammation in patients with UC. CCE allows noninvasive evaluation of mucosal inflammation with a reduced volume of preparation for patients with UC.
KW - Crohn's disease
KW - capsule endoscopy
KW - inflammatory bowel disease
KW - pan-enteric capsule endoscopy
KW - ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=85138206911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138206911&partnerID=8YFLogxK
U2 - 10.1002/deo2.26
DO - 10.1002/deo2.26
M3 - Review article
AN - SCOPUS:85138206911
SN - 2692-4609
VL - 2
JO - DEN Open
JF - DEN Open
IS - 1
M1 - e26
ER -